Learn more

CHROMA THERAPEUTICS LTD

Overview
  • Total Patents
    325
  • GoodIP Patent Rank
    170,560
  • Filing trend
    ⇩ 100.0%
About

CHROMA THERAPEUTICS LTD has a total of 325 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1999. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SYNTA PHARMACEUTICALS, GALILEO PHARMACEUTICALS INC and ACADIA PHARM INC.

Patent filings per year

Chart showing CHROMA THERAPEUTICS LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Moffat David Festus Charles 154
#2 Davies Stephen John 89
#3 Davidson Alan Hornsby 69
#4 Drummond Alan Hastings 64
#5 Patel Sanjay Ratilal 64
#6 Donald Alistair David Graham 35
#7 Charlton Michael Hugh 32
#8 Pintat Stephane 26
#9 Baker Kenneth William John 25
#10 Belfield Andrew James 24

Latest patents

Publication Filing date Title
GB201322098D0 MEK-1, 2 kinase inhibitors
SG11201502515VA Tert-butyl n-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2h)-yl]-3,5- difluorophenyl}ethyl]-l-alaninate or a salt, hydrate or solvate thereof
GB201306901D0 Combination
GB201306881D0 Chemical compounds
GB201218640D0 Chemical compounds
GB201211310D0 CSF-1R kinase inhibitors
GB201021467D0 Imaging agents
WO2012025701A1 Alpha, alpha - di substituted glycine ester derivatives and their use as hdac inhibitors
GB201009853D0 HSP90 inhibitors
GB0907120D0 Inhibitors of IKK-ß serine-threonine protein kinase
AU2009239772A1 Substituted thiophenecarboxamides as IKK-beta serine-, threonine-protein kinase inhibitors
ZA200902824B Hydroxamates as inhibitors of histone deacetylase
GB0903651D0 Inhibitors of glyoxalase
GB0903650D0 Glyoalase inhibitors
GB0903480D0 Enzyme Inhibitors
WO2009106844A1 Inhibitors of p38 map kinase
GB0819105D0 Pyrrolo-pyrimidine compounds
GB0819102D0 Pyrrolo-pyrimidine compounds
GB0815544D0 Inhibitors of p38 map kinase
GB0815550D0 IKK-beta serine-threonine protein kinase inhibitors